Treatment of patients with Covid-19 with a high dose of ulinastatin

Currently, there are no specific therapeutic agents available for the treatment of coronavirus disease 2019 (Covid-19). The present study aimed to assess the efficacy of high-dose ulinastatin for the treatment of patients with Covid-19. A total of 12 patients hospitalized with confirmed severe acute...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Hai, Hu, Ping-Fang, Sun, Liang-Liang, Guo, Yi-Bin, Wang, Qiong, Liu, Zhi-Min, Yin, Ji-Zhong, Shi, Pei-Mei, Yuan, Zong-Li, Xie, Wei-Fen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8713169/
https://www.ncbi.nlm.nih.gov/pubmed/34970344
http://dx.doi.org/10.3892/etm.2021.11044

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8713169/
https://www.ncbi.nlm.nih.gov/pubmed/34970344
http://dx.doi.org/10.3892/etm.2021.11044

Ejemplares similares